BFTHX
Price
$65.50
Change
-$0.77 (-1.16%)
Updated
Oct 14 closing price
Net Assets
772.71M
RGACX
Price
$84.65
Change
-$0.31 (-0.36%)
Updated
Oct 14 closing price
Net Assets
338.36B
Interact to see
Advertisement

BFTHX vs RGACX

Header iconBFTHX vs RGACX Comparison
Open Charts BFTHX vs RGACXBanner chart's image
Baron Fifth Avenue Growth Retail
Price$65.50
Change-$0.77 (-1.16%)
VolumeN/A
Net Assets772.71M
American Funds Growth Fund of Amer R3
Price$84.65
Change-$0.31 (-0.36%)
VolumeN/A
Net Assets338.36B
BFTHX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
BFTHX vs. RGACX commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFTHX is a Hold and RGACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 338B vs. BFTHX (773M). RGACX pays higher dividends than BFTHX: RGACX (0.07) vs BFTHX (0.00). BFTHX was incepted earlier than RGACX: BFTHX (21 years) vs RGACX (23 years). BFTHX (1.03) is less costly to investors than RGACX (0.94). BFTHX (26.00) and RGACX (25.00) have comparable annual turnover. RGACX has a lower initial minimum investment than BFTHX: RGACX (250) vs BFTHX (2000). BFTHX annual gain was more profitable for investors over the last year : 21.83 vs. RGACX (10.09). RGACX return over 5 years is better than : 37.57 vs. BFTHX (33.94).
BFTHXRGACXBFTHX / RGACX
Total Expense Ratio1.000.94106%
Annual Report Gross Expense Ratio1.030.94110%
Fund Existence21 years23 years-
Gain YTD14.52217.58683%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets773M338B0%
Annual Yield % from dividends0.000.07-
Returns for 1 year21.8310.09216%
Returns for 3 years145.0277.52187%
Returns for 5 years33.9437.5790%
Returns for 10 years263.6695.94275%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMPH23.870.36
+1.53%
Amphastar Pharmaceuticals
ACLX87.331.10
+1.28%
Arcellx
FACT10.31N/A
N/A
Fact II Acquisition Corp
NDLS0.65N/A
-0.15%
Noodles & Company
NXPI216.11-0.59
-0.27%
NXP Semiconductors NV